Verisk Analytics, Inc. (LON:0LP3)

CTI BioPharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	28,678	31,067	27,188	22,898	27,224	24,721
Market Cap Growth	4.52%	14.27%	18.74%	-15.89%	10.12%	33.79%
Enterprise Value	30,791	33,307	29,299	25,721	29,530	27,075
Last Close Price	206.70	219.60	185.55	144.86	164.77	143.49
PE Ratio	42.89	40.59	56.35	28.92	55.33	47.36
PS Ratio	13.16	13.50	12.92	11.05	14.97	14.87
PB Ratio	125.69	370.42	107.48	15.61	12.97	12.51
P/FCF Ratio	38.50	42.27	41.69	35.18	41.55	41.09
P/OCF Ratio	31.67	34.00	32.65	26.05	31.90	31.60
EV/Sales Ratio	13.66	14.47	13.92	12.41	16.24	16.29
EV/EBITDA Ratio	27.66	30.34	29.85	18.99	33.71	30.91
EV/EBIT Ratio	30.84	33.05	32.90	22.01	43.74	38.57
EV/FCF Ratio	41.34	45.32	44.93	39.51	45.06	45.00
Debt / Equity Ratio	10.97	30.91	9.61	2.24	1.26	1.31
Debt / EBITDA Ratio	2.32	2.31	2.41	2.36	2.89	2.82
Debt / FCF Ratio	3.36	3.53	3.73	5.04	4.03	4.29
Asset Turnover	0.63	0.67	0.47	0.34	0.32	0.31
Quick Ratio	1.41	0.65	0.86	0.19	0.25	0.48
Current Ratio	1.53	0.74	1.05	0.40	0.49	0.56
Return on Equity (ROE)	243.11%	445.08%	73.53%	45.21%	21.91%	26.37%
Return on Assets (ROA)	17.29%	18.27%	12.52%	11.92%	7.43%	8.20%
Return on Capital (ROIC)	22.14%	23.30%	15.51%	14.50%	9.04%	10.08%
Return on Capital Employed (ROCE)	33.90%	41.70%	31.60%	30.30%	15.30%	15.60%
Earnings Yield	2.33%	2.46%	1.77%	3.46%	1.81%	2.11%
FCF Yield	2.60%	2.37%	2.40%	2.84%	2.41%	2.43%
Dividend Yield	0.46%	0.57%	0.57%	0.71%	0.52%	0.55%
Payout Ratio	25.76%	23.09%	32.02%	20.46%	28.25%	24.67%
Buyback Yield / Dilution	2.25%	3.05%	7.29%	2.70%	1.20%	0.74%
Total Shareholder Return	2.72%	3.62%	7.87%	3.41%	1.72%	1.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.